标题
NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment
作者
关键词
-
出版物
PATHOLOGY INTERNATIONAL
Volume 68, Issue 11, Pages 583-595
出版商
Wiley
发表日期
2018-10-26
DOI
10.1111/pin.12727
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CIC-NUTM1 Fusion: A Case Which Expands the Spectrum of NUT -Rearranged Epithelioid Malignancies
- (2018) Inga-Marie Schaefer et al. GENES CHROMOSOMES & CANCER
- A novel prognostic risk classification model for NUT midline carcinoma: a largest cohort analysis from the NMC registry.
- (2018) Nicole Grace Chau et al. JOURNAL OF CLINICAL ONCOLOGY
- 'Z4' Complex Member Fusions in NUT Carcinoma: Implications for a Novel Oncogenic Mechanism
- (2018) Hitoshi Shiota et al. MOLECULAR CANCER RESEARCH
- The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
- (2017) Yu Liu et al. NATURE GENETICS
- Pediatric NUT-midline carcinoma: Therapeutic success employing a sarcoma based multimodal approach
- (2017) Simone Storck et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Ectopic protein interactions within BRD4–chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma
- (2017) Artyom A. Alekseyenko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular-genetic profiling and high-throughput in vitro drug screening in NUT midline carcinoma—an aggressive and fatal disease
- (2017) Anja Stirnweiss et al. Oncotarget
- Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma
- (2017) Johannes Brägelmann et al. Cell Reports
- Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck
- (2016) Nicole G. Chau et al. CANCER
- Cytopathologic features of NUT midline carcinoma: A series of 26 specimens from 13 patients
- (2016) Justin A. Bishop et al. CANCER CYTOPATHOLOGY
- New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs
- (2016) Dominik Sturm et al. CELL
- Dual HDAC and PI3K Inhibitor CUDC-907 Downregulates MYC and Suppresses Growth of MYC-dependent Cancers
- (2016) Kaiming Sun et al. MOLECULAR CANCER THERAPEUTICS
- Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
- (2016) Shaokun Shu et al. NATURE
- Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia
- (2016) Henrik Lilljebjörn et al. Nature Communications
- Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia
- (2016) Zhaohui Gu et al. Nature Communications
- Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628
- (2016) A. Stathis et al. Cancer Discovery
- Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
- (2016) Céline Berthon et al. Lancet Haematology
- Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study
- (2016) Sandy Amorim et al. Lancet Haematology
- Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia
- (2016) Yuan-Fang Liu et al. EBioMedicine
- The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs
- (2015) M. Boi et al. CLINICAL CANCER RESEARCH
- Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition
- (2015) A. Henssen et al. CLINICAL CANCER RESEARCH
- Nuclear protein in testis midline carcinoma with unusual elevation of α-fetoprotein and synaptophysin positivity: a case report and review of the literature
- (2015) Anwar Raza et al. Expert Review of Anticancer Therapy
- The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains
- (2015) Artyom A. Alekseyenko et al. GENES & DEVELOPMENT
- Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations
- (2015) Lynette M. Sholl et al. Journal of Thoracic Oncology
- The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias
- (2015) Anna K Andersson et al. NATURE GENETICS
- The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models
- (2015) P L Garcia et al. ONCOGENE
- Histone deacetylase inhibitor for NUT midline carcinoma
- (2015) Ossama M. Maher et al. PEDIATRIC BLOOD & CANCER
- A novel BRD4-NUT fusion in an undifferentiated sinonasal tumor highlights alternative splicing as a contributing oncogenic factor in NUT midline carcinoma
- (2015) A Stirnweiss et al. Oncogenesis
- Comparative drug screening in NUT midline carcinoma
- (2014) A H Beesley et al. BRITISH JOURNAL OF CANCER
- Disrupting the Interaction of BRD4 with Diacetylated Twist Suppresses Tumorigenesis in Basal-like Breast Cancer
- (2014) Jian Shi et al. CANCER CELL
- Mechanistic Analysis of the Role of Bromodomain-containing Protein 4 (BRD4) in BRD4-NUT Oncoprotein-induced Transcriptional Activation
- (2014) Ranran Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Highly Active Combination of BRD4 Antagonist and Histone Deacetylase Inhibitor against Human Acute Myelogenous Leukemia Cells
- (2014) W. Fiskus et al. MOLECULAR CANCER THERAPEUTICS
- Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
- (2014) Irfan A. Asangani et al. NATURE
- A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia
- (2014) Daniel Herranz et al. NATURE MEDICINE
- NSD3-NUT Fusion Oncoprotein in NUT Midline Carcinoma: Implications for a Novel Oncogenic Mechanism
- (2014) C. A. French et al. Cancer Discovery
- Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma
- (2013) Bjoern Chapuy et al. CANCER CELL
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
- (2013) Jakob Lovén et al. CELL
- Efficacy of BET Bromodomain Inhibition in Kras-Mutant Non-Small Cell Lung Cancer
- (2013) T. Shimamura et al. CLINICAL CANCER RESEARCH
- The bromodomain protein Brd4 insulates chromatin from DNA damage signalling
- (2013) Scott R. Floyd et al. NATURE
- MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma
- (2013) A R Grayson et al. ONCOGENE
- Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
- (2013) Alexandre Puissant et al. Cancer Discovery
- Expression of P16 in NUT Carcinomas With No Association With Human Papillomavirus (HPV)
- (2013) Paulo Guilherme de Oliveira Salles et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- NUT Midline Carcinoma
- (2012) Mio Tanaka et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- NUT Midline Carcinomas of the Sinonasal Tract
- (2012) Justin A. Bishop et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Pathologic Characteristics of NUT Midline Carcinoma Arising in the Mediastinum
- (2012) Andrew G. Evans et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma
- (2012) D. E. Bauer et al. CLINICAL CANCER RESEARCH
- NUT Rearrangement is Uncommon in Human Thymic Epithelial Tumors
- (2012) Iacopo Petrini et al. Journal of Thoracic Oncology
- Novel BRD4–NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma
- (2012) K Thompson-Wicking et al. ONCOGENE
- Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins
- (2012) W. W. Lockwood et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pathogenesis of NUT Midline Carcinoma
- (2011) Christopher A. French Annual Review of Pathology-Mechanisms of Disease
- Differentiation of NUT Midline Carcinoma by Epigenomic Reprogramming
- (2011) B. E. Schwartz et al. CANCER RESEARCH
- Two-pronged Binding with Bromodomain-containing Protein 4 Liberates Positive Transcription Elongation Factor b from Inactive Ribonucleoprotein Complexes
- (2011) Sebastian Schröder et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Brd4 Extraterminal Domain Confers Transcription Activation Independent of pTEFb by Recruiting Multiple Proteins, Including NSD3
- (2011) S. Rahman et al. MOLECULAR AND CELLULAR BIOLOGY
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- (2011) Johannes Zuber et al. NATURE
- Targeting MYC dependence in cancer by inhibiting BET bromodomains
- (2011) J. A. Mertz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
- (2011) N. Stransky et al. SCIENCE
- Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains
- (2010) Nicolas Reynoird et al. EMBO JOURNAL
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Carcinomas of the Upper Aerodigestive Tract With Rearrangement of the Nuclear Protein of the Testis (NUT) Gene (NUT Midline Carcinomas)
- (2009) Edward B. Stelow et al. ADVANCES IN ANATOMIC PATHOLOGY
- NUT Midline Carcinoma of the Parotid Gland With Mesenchymal Differentiation
- (2009) Michael A. den Bakker et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Diagnosis of NUT Midline Carcinoma Using a NUT-specific Monoclonal Antibody
- (2009) Herbert Haack et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- NUT Midline Carcinoma in a Newborn with Multiorgan Disseminated Tumor and a 2-Year-Old with a Pancreatic/Hepatic Primary
- (2009) Bahig M. Shehata et al. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
- NUT Rearrangement in Undifferentiated Carcinomas of the Upper Aerodigestive Tract
- (2008) Edward B. Stelow et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More